MARGARET PONS: Open Payments
NPI 1538819503 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 9 payments from 7 companies in 2025. Trend: 2023 $120 · 2024 $96 · 2025 $419
Food & beverage: $320Education: $99
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $224 |
| AstraZeneca Pharmaceuticals LP | 2 | $61 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| ABBVIE INC. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| SpringWorks Therapeutics, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: DATROWAY, Enhertu, KISQALI, ELAHERE, Stivarga, ICLUSIG.
Industry payments across MD — which companies pay providers there.
